MARKET

AXDX

AXDX

Accelerate Diagnostics Inc
NASDAQ
0.6750
-0.0627
-8.50%
Closed 16:00 05/30 EDT
OPEN
0.7400
PREV CLOSE
0.7377
HIGH
0.7500
LOW
0.6626
VOLUME
339.69K
TURNOVER
141.40K
52 WEEK HIGH
3.737
52 WEEK LOW
0.4501
MARKET CAP
67.39M
P/E (TTM)
-0.9043
1D
5D
1M
3M
1Y
5Y
Accelerate Diagnostics Inc: Securities to be offered to employees in employee benefit plans, post-effective amendments
Press release · 13h ago
BRIEF-Accelerate Diagnostics And Required Consenting Noteholders Agree To Further Extend Consent Condition Milestone
Reuters · 22h ago
Accelerate Diagnostics Inc: Statement of changes in beneficial ownership of securities
Press release · 4d ago
Accelerate Diagnostics Inc: Current report
Press release · 6d ago
Accelerate Diagnostics Inc: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 05/17 16:36
Accelerate Diagnostics Inc: Quarterly report
Press release · 05/15 17:10
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
NASDAQ · 05/11 21:25
BRIEF-Accelerate Diagnostics Reports First Quarter 2023 Financial Results
Reuters · 05/11 21:03
More
About AXDX
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company. The Company is engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. Its in-vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk.

Webull offers kinds of Accelerate Diagnostics Inc stock information, including NASDAQ:AXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXDX stock methods without spending real money on the virtual paper trading platform.